Literature DB >> 21411531

Nonconserved lysine residues attenuate the biological function of the low-risk human papillomavirus E7 protein.

Nicholas J Genovese1, Thomas R Broker, Louise T Chow.   

Abstract

The mucosotrophic human papillomaviruses (HPVs) are classified as high-risk (HR) or low-risk (LR) genotypes based on their neoplastic properties. We have demonstrated previously that the E7 protein destabilizes p130, a pRb-related pocket protein, thereby promoting S-phase reentry in postmitotic, differentiated keratinocytes of squamous epithelia, and that HR HPV E7 does so more efficiently than LR HPV E7. The E7 proteins of LR HPV-11 and -6b uniquely possess lysine residues following a casein kinase II phosphorylation motif which is critical for the biological function of E7. We now show that mutations of these lysine residues elevated the efficiency of S-phase reentry, independent of their charge. An 11E7 K39,42R mutation moderately increased the association with and the destabilization of p130. Unexpectedly, polyubiquitination on these lysine residues did not attenuate E7 activity, as their mutation caused elevated proteasomal degradation and decreased protein stability. In this regard, the biologically more potent HR HPV E7 proteins were also less stable than the LR HPV E7 proteins. We infer that these lysine residues impede functional protein-protein interactions. A G22D mutation of 11E7 at the pocket protein binding motif possessed augmented efficiency in promoting S-phase reentry and strongly enhanced association with p130 and pRb. The combined effects of these two classes of 11E7 mutations exhibited an efficiency of S-phase reentry comparable to that of HR HPV E7. Thus, these nonconserved residues are primarily responsible for the differential abilities of LR and HR HPV E7 proteins to promote unscheduled DNA replication in organotypic raft cultures.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21411531      PMCID: PMC3094958          DOI: 10.1128/JVI.02166-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  67 in total

Review 1.  Human papillomavirus oncoproteins: pathways to transformation.

Authors:  Cary A Moody; Laimonis A Laimins
Journal:  Nat Rev Cancer       Date:  2010-07-01       Impact factor: 60.716

2.  Compromised spindle assembly checkpoint due to altered expression of Ubch10 and Cdc20 in human papillomavirus type 16 E6- and E7-expressing keratinocytes.

Authors:  Daksha Patel; Dennis J McCance
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

3.  Human papillomavirus (HPV) E7 induces prolonged G2 following S phase reentry in differentiated human keratinocytes.

Authors:  N Sanjib Banerjee; Hsu-Kun Wang; Thomas R Broker; Louise T Chow
Journal:  J Biol Chem       Date:  2011-02-14       Impact factor: 5.157

4.  Human papillomavirus E7 proteins stimulate proliferation independently of their ability to associate with retinoblastoma protein.

Authors:  S Caldeira; E M de Villiers; M Tommasino
Journal:  Oncogene       Date:  2000-02-10       Impact factor: 9.867

5.  The nuclear localization of low risk HPV11 E7 protein mediated by its zinc binding domain is independent of nuclear import receptors.

Authors:  Zachary Piccioli; Courtney H McKee; Anna Leszczynski; Zeynep Onder; Erin C Hannah; Shahan Mamoor; Lauren Crosby; Junona Moroianu
Journal:  Virology       Date:  2010-08-30       Impact factor: 3.616

6.  Identification of the nuclear localization and export signals of high risk HPV16 E7 oncoprotein.

Authors:  Alixandra A Knapp; Patrick M McManus; Katy Bockstall; Junona Moroianu
Journal:  Virology       Date:  2008-11-08       Impact factor: 3.616

7.  Targeting mechanism of the retinoblastoma tumor suppressor by a prototypical viral oncoprotein. Structural modularity, intrinsic disorder and phosphorylation of human papillomavirus E7.

Authors:  Lucía B Chemes; Ignacio E Sánchez; Clara Smal; Gonzalo de Prat-Gay
Journal:  FEBS J       Date:  2010-01-20       Impact factor: 5.542

8.  Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes.

Authors:  Hsu-Kun Wang; Aaron A Duffy; Thomas R Broker; Louise T Chow
Journal:  Genes Dev       Date:  2009-01-08       Impact factor: 11.361

9.  DYRK1A stabilizes HPV16E7 oncoprotein through phosphorylation of the threonine 5 and threonine 7 residues.

Authors:  Yuh-Jin Liang; Hung-Shu Chang; Chen-Yu Wang; Winston C Y Yu
Journal:  Int J Biochem Cell Biol       Date:  2008-04-06       Impact factor: 5.085

10.  Functional overlap of sequences that activate transcription and signal ubiquitin-mediated proteolysis.

Authors:  S E Salghetti; M Muratani; H Wijnen; B Futcher; W P Tansey
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

View more
  9 in total

Review 1.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

2.  Immunologic responses to a novel DNA vaccine targeting human papillomavirus-11 E6E7.

Authors:  Julie Ahn; Shiwen Peng; Chien-Fu Hung; Richard B S Roden; Tzyy-Choou Wu; Simon R Best
Journal:  Laryngoscope       Date:  2017-07-17       Impact factor: 3.325

Review 3.  Model systems to study the life cycle of human papillomaviruses and HPV-associated cancers.

Authors:  Louise T Chow
Journal:  Virol Sin       Date:  2015-04-23       Impact factor: 4.327

4.  Tissue Engineering for Cervical Function in Pregnancy.

Authors:  Yali Zhang; David Kaplan; Michael D House
Journal:  Curr Opin Biomed Eng       Date:  2022-03-28

Review 5.  Human papillomavirus infections: warts or cancer?

Authors:  Louise T Chow; Thomas R Broker
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-07-01       Impact factor: 10.005

Review 6.  The papillomavirus E7 proteins.

Authors:  Ann Roman; Karl Munger
Journal:  Virology       Date:  2013-05-31       Impact factor: 3.616

7.  Vorinostat, a pan-HDAC inhibitor, abrogates productive HPV-18 DNA amplification.

Authors:  N Sanjib Banerjee; Dianne W Moore; Thomas R Broker; Louise T Chow
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-01       Impact factor: 11.205

8.  Functional Constraint Profiling of a Viral Protein Reveals Discordance of Evolutionary Conservation and Functionality.

Authors:  Nicholas C Wu; C Anders Olson; Yushen Du; Shuai Le; Kevin Tran; Roland Remenyi; Danyang Gong; Laith Q Al-Mawsawi; Hangfei Qi; Ting-Ting Wu; Ren Sun
Journal:  PLoS Genet       Date:  2015-07-01       Impact factor: 5.917

9.  Targeting DNA Damage Response as a Strategy to Treat HPV Infections.

Authors:  N Sanjib Banerjee; Dianne Moore; Cameron J Parker; Thomas R Broker; Louise T Chow
Journal:  Int J Mol Sci       Date:  2019-11-01       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.